p53 accumulation and apoptosis in embolized meningiomas

Acta Neuropathologica

Volumn 93, Issue 6, 1997, Pages 599-605

  Nakasu, Satoshi ^a   Nakajima, Masayuki ^a   Nakazawa, Takuya ^a   Nakasu, Yoko ^a   Handa, Jyoji ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Apoptosis; Meningioma; MIB 1; p21; p53

Indexed keywords

PROTEIN P21; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; ARTIFICIAL EMBOLISM; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MENINGIOMA; PRIORITY JOURNAL;

ADULT; AGED; ANTIBODIES, MONOCLONAL; APOPTOSIS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; DNA NUCLEOTIDYLEXOTRANSFERASE; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; MITOTIC INDEX; NEOPLASM CIRCULATING CELLS; STAINING AND LABELING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031011599     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050657     Document Type: Article

References (34)

1. Ansari B, Cates PJ, Greenstein BD, Hall PA (1993) In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 170: 1-8
2. Barac Y, Juven T, Haffner R, Oren M (1993) mdm2 expression is induced by wild type p53 activity. EMBO J 12: 461-468
3. Cattoretti G, Becker MHG, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant part of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferatina cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357-363
4. Chen X, Bargonetti J, Prives C (1995) p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis. Cancer Res 55: 4257-4263
5. Dean BL, Flom RA, Wallace RC, Khayata MH, Obuchowski NA, Hodak JA (1994) Efficacy of endovascular treatment of meningiomas: evaluation with matched samples. AJNR 15: 1675-1680
6. Di Leonardo A, Linke SP, Clarkin K, Wahl GM (1994) DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Gene Dev 8: 2540-2551
7. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-823
8. El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW, Vogelstein B (1995) Topological control of p21 WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 55: 2910-2919
9. Ellison DW, Lunec J, Gallagher PJ, Steart PV, Jaros E, Gatter KC (1995) Accumulation of wild-type p53 in meningiomas. Neuropathol Appl Neurobiol 21: 136-142
10. Gavreli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501
11. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91
12. Harper JW, Adami GR, Wei N, Keyomrsi K, Elledge SJ (1993) The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816
13. Hupp TR, Sparks A, Lane DP (1995) Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83: 237-245
14. Irikura K, Miyasaka Y, Yada K, Kan S (1992) Preoperative embolization for meningiomas using PVA particles (in Japanese). No Shinkei Geka 20: 367-373
15. Karamitopoulou E, Perentes E, Diamantis I (1993) p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-1 monoclonal antibodies. Acta Neuropathol 85: 611-616
16. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311
17. Kerr JF, Winterford CM, Harmon BV (1994) Apoptosis. Its significance in cancer and cancer therapy. Cancer 73: 2013-2026
18. Koike T, Sasaki O, Tanaka R, Arai H (1990) Long-term results in a case of meningioma treated by embolization alone - case report. Neurol Med Chir (Tokyo) 30: 173-177
19. Lan HY, Mu W, Nikolic-Paterson DJ, Atkins RC (1995) A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem 43: 97-102
20. Li Y, Chopp M, Zhang ZG, Zaloga C, Niewenhuis L, Gautam S (1994) p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke 25: 849-856
21. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T (1995) p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Gene Dev 9: 935-944
22. Manelfe C, Lasjaunias P, Ruscalleda J (1986) Preoperative embolization of intracranial meningiomas. AJNR 7: 963-972
23. Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K (1991) Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6: 1313-1318
24. Morimura T, Takeuchi J, Maeda Y, Tani E (1994) Preoperative embolization of meningiomas: its efficacy and histopathological findings. Brain Tumor Pathol 11: 123-129
25. Nakasu S, Nakasu Y, Nioka H, Nakajima M, Handa J (1994) bcl-2 protein expression in tumors of the central nervous system. Acta Neuropathol 88: 520-526
26. Nakasu S, Nakajima, M, Matsumura K, Nakasu Y, Handa J (1995) Meningioma: proliferating potential and clinicoradiological features. Neurosurgery 37: 1049-1055
27. Nakasu S, Nakasu Y, Nakajima M, Yokoyama M, Matsuda M, Handa J (1996) Potential doubling time and tumor doubling time in meningiomas and neurinomas. Acta Neurochir (Wien) 138: 763-770
28. Ng HK, Poon WS, Goh K, Chan MSY (1996) Histopathology of post-embolized meningiomas. Am J Surg Pathol 20: 1224-1230
29. Ohgaki H, Eibl RH, Schwab M, Reichel MB, Mariani L, Gehring M. Petersen I, Höll T, Wiestler OD, Kleihues P (1993) Mutation of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog 8: 74-80
30. Paulus W, Meixensberger J, Hofmann E, Roggendorf W (1993) Effect of embolisation of meningioma on Ki-67 proliferation index. J Clin Pathol 46: 876-877
31. Teasdale E, Patterson J, McLellan D, Macpherson P (1984) Superselective preoperative embolization for meningiomas. A radiological and pathological assessment. J Neurosurg 60: 506-511
32. Van Dierendonck JH, Keijzer R, Van de Velde CJH, Cornelisse CJ (1989) Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res 49: 2999-3006
33. Wakhloo AK, Juengling FD, Van-Velthoven V, Schumacher M, Hennig J, Schwechheimer K (1993) Extended preoperative polyvinyl alcohol microembolization of intracranial meningiomas: assessment of two embolization techniques. AJNR 14: 571-582
34. Wang J-L, Zhang Z-J, Hartman M, Smits A, Westermark B, Muhr C, Nister M (1995) Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples. Int J Cancer (Pred Oncol) 64: 223-228